Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Talk to a qualified clinician before considering any use
One study found that exenatide, a GLP-1 agonist that was approved to treat Type 2 diabetes back in 2005, significantly reduced the alcohol-cue reactivity in the area of the brain related to drug reward and addiction and significantly reduced the total alcohol intake in patients with obesity in particular
It works by mimicking a hormone in your body called GLP-1, which helps control blood sugar levels and appetite
With the right support and monitoring, these issues can often be managed or avoided altogether
First authorized for type 2 diabetes and then obesity, GLP-1 RAs such as liraglutide and semaglutide suppress appetite, increase insulin sensitivity, and reduce weight by significant amounts that make a difference to fertility
